Top compounds associated with response to NRG2


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC 0.22 0.001
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.1 0.001
mRNA paclitaxel FIMM pan-cancer AAC -0.41 0.001
mRNA bendamustine CTRPv2 pan-cancer AAC -0.12 0.002
mRNA canertinib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Imatinib GDSC1000 pan-cancer AAC -0.16 0.002
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.11 0.003
Download CSV